More recently, genome-wide association studies have highlighted a novel role of FOXE1 as a susceptibility gene for thyroid cancer by identifying several non-coding SNPs linked to increased risk of developing PTC [5,6,7]. This evidence concerns the gene FOXE1 and thyroid gland carcinoma.